Dr. Agarwal’s Eye Hospital Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹2263
- Today's High:
- ₹2488.95
- Open Price:
- ₹2453.65
- 52W Low:
- ₹788.6717
- 52W High:
- ₹2395
- Prev. Close:
- ₹2453.65
- Volume:
- 6576
Company Statistics
- Market Cap.:
- ₹1.06 billion
- Book Value:
- 102.931
- Revenue TTM:
- ₹1.30 billion
- Operating Margin TTM:
- 2.59%
- Gross Profit TTM:
- ₹1.16 billion
- Profit Margin:
- -1.5%
- Return on Assets TTM:
- 1.47%
- Return on Equity TTM:
- -3.94%
Company Profile
Dr. Agarwal’s Eye Hospital Limited had its IPO on under the ticker symbol 526783.
The company operates in the Other sector and Other industry. Dr. Agarwal’s Eye Hospital Limited has a staff strength of 772 employees.
Stock update
Shares of Dr. Agarwal’s Eye Hospital Limited opened at ₹2453.65 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹2263 - ₹2488.95, and closed at ₹2297.2.
This is a -6.38% slip from the previous day's closing price.
A total volume of 6,576 shares were traded at the close of the day’s session.
In the last one week, shares of Dr. Agarwal’s Eye Hospital Limited have slipped by -7.54%.
Dr. Agarwal’s Eye Hospital Limited's Key Ratios
Dr. Agarwal’s Eye Hospital Limited has a market cap of ₹1.06 billion, indicating a price to book ratio of 2.3292 and a price to sales ratio of 0.8765.
In the last 12-months Dr. Agarwal’s Eye Hospital Limited’s revenue was ₹1.30 billion with a gross profit of ₹1.16 billion and an EBITDA of ₹107.82 million. The EBITDA ratio measures Dr. Agarwal’s Eye Hospital Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Dr. Agarwal’s Eye Hospital Limited’s operating margin was 2.59% while its return on assets stood at 1.47% with a return of equity of -3.94%.
In Q3, Dr. Agarwal’s Eye Hospital Limited’s quarterly earnings growth was a positive 0% while revenue growth was a negative 33.2%.
Dr. Agarwal’s Eye Hospital Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 86.8914
- PEG
Its diluted EPS in the last 12-months stands at ₹-4.154 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Dr. Agarwal’s Eye Hospital Limited’s profitability.
Dr. Agarwal’s Eye Hospital Limited stock is trading at a EV to sales ratio of 1.2312 and a EV to EBITDA ratio of 6.5658. Its price to sales ratio in the trailing 12-months stood at 0.8765.
Dr. Agarwal’s Eye Hospital Limited stock pays annual dividends of ₹ per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹3.90 billion
- Total Liabilities
- ₹550.80 million
- Operating Cash Flow
- ₹-706100000.00
- Capital Expenditure
- ₹708.40 million
- Dividend Payout Ratio
- 0%
Dr. Agarwal’s Eye Hospital Limited ended 2024 with ₹3.90 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹3.90 billion while shareholder equity stood at ₹1.13 billion.
Dr. Agarwal’s Eye Hospital Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹550.80 million in other current liabilities, 47000000.00 in common stock, ₹1.09 billion in retained earnings and ₹1.80 million in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹302.10 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹357.70 million.
Dr. Agarwal’s Eye Hospital Limited’s total current assets stands at ₹465.40 million while long-term investments were ₹0 and short-term investments were ₹21.10 million. Its net receivables were ₹101.10 million compared to accounts payable of ₹0 and inventory worth ₹60.00 million.
In 2024, Dr. Agarwal’s Eye Hospital Limited's operating cash flow was ₹-706100000.00 while its capital expenditure stood at ₹708.40 million.
Comparatively, Dr. Agarwal’s Eye Hospital Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹2297.2
- 52-Week High
- ₹2395
- 52-Week Low
- ₹788.6717
- Analyst Target Price
- ₹
Dr. Agarwal’s Eye Hospital Limited stock is currently trading at ₹2297.2 per share. It touched a 52-week high of ₹2395 and a 52-week low of ₹2395. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹1845.69 and 200-day moving average was ₹1356.75 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 7920.9% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Dr. Agarwal’s Eye Hospital Limited
Similar Industry Stocks (Other)
Most Active
Top Gainers
Top Losers
About
Dr. Agarwal’s Eye Hospital Limited operates hospitals, nursing homes, clinics, medical and research facilities, and other institutions for eye care and treatment in India and internationally. The company offers services in the areas of cataract, glaucoma, laser correction, cornea and refractive, retina, squint, pediatric and neuro ophthalmology, uvea, and orbit and oculoplasty, as well as provides other health related services. It is also involved in the operation of other health care facilities; and hospital related trading and other activities. The company was founded in 1957 and is based in Chennai, India. Dr. Agarwal’s Eye Hospital Limited is a subsidiary of Dr. Agarwal’s Health Care Limited.